A short peptide potentially promotes the healing of skin wound

Biosci Rep. 2019 Mar 22;39(3):BSR20181734. doi: 10.1042/BSR20181734. Print 2019 Mar 29.

Abstract

Skin wound, a common form of skin damage in daily life, remains a serious challenge in clinical treatment. Bioactive peptides with high efficiency have been considered as potential therapeutic candidates for wound healing. In this report, a novel short linear peptide, with mature peptide sequence of 'GLLSGINAEWPC' and no obvious similarity with other known bioactive peptides, was identified by genomic method from the skin of odorous frog, Odorrana andersonii Our results suggested that OA-GL12 (OA: abbreviation of species (O. andersonii), GL: two initial amino acids, 12: peptide length) obviously accelerated the scratch-healing of keratinocytes and human fibroblasts in a time- and concentration-dependent manner. Meanwhile, OA-GL12 showed significant effect in promoting the wound healing on the full-thickness skin wound model. Inflammatory assay results demonstrated that OA-GL12 induced the secretion of tumor necrosis factor (TNF) and transforming growth factor β1 (TGF-β1) on murine macrophage cell line (RAW264.7), which might explain the powerful accelerating capacity of wound healing. Moreover, results also indicated that epidermal growth factor receptor (EGFR) was involved in the mechanisms underlying the scratch-healing promoting activity of OA-GL12. In addition, OA-GL12 showed obvious free radical scavenging activity. Results supported that OA-GL12 did not exert risk in acute toxicity, hemolytic activity, and direct antibacterial activity. The remarkable effect of OA-GL12 on promoting wound healing verified in this research made it potential to be a novel template for the development of wound healing-promoting agents.

Keywords: Odorrana andersonii; TGF-β1; bioactive peptide; skin; wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Base Sequence
  • Cell Line
  • Cell Movement / drug effects
  • Fibroblasts / drug effects
  • Fibroblasts / pathology
  • Humans
  • Keratinocytes / drug effects*
  • Keratinocytes / pathology
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Male
  • Mice
  • Peptides / chemistry
  • Peptides / genetics
  • Peptides / pharmacology*
  • RAW 264.7 Cells
  • Ranidae / genetics
  • Ranidae / metabolism
  • Skin / drug effects*
  • Skin / pathology
  • Transforming Growth Factor beta1 / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Wound Healing / drug effects*

Substances

  • Anti-Infective Agents
  • Peptides
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha